EAM
ELOS

Exane Asset Management’s Syneron Medical Ltd ELOS Stock Holding History

Exane Asset Management’s Portfolio ELOS Stock Details ELOS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q3 		– Sell
-20,000
Closed -$219K – 166
2017
Q2 		$219K Buy
+20,000
New +$219K 0.07% 49

Other funds holding ELOS

BIP
Brandes Investment Partners La Jolla, California $14.1B AUM 25.52% 1-Year Est. Return
LAM
Lapides Asset Management Greenwich, Connecticut $153M AUM 9.03% 1-Year Est. Return
GLAM
Gardner Lewis Asset Management Chadds Ford, Pennsylvania $462M AUM 65.29% 1-Year Est. Return
AIM
Acrospire Investment Management Chicago, Illinois $33K AUM 23.36% 1-Year Est. Return

Exane Asset Management's ELOS Position: Q3 2017 in Review

Exane Asset Management sold out of Syneron Medical Ltd (ELOS) in Q3 2017, closing a stake of 20,000 shares — an estimated $219K sold.

Exane Asset Management first reported a position in ELOS in Q2 2017 and held it in 1 quarter. The position peaked at $219K in Q2 2017. 4 funds tracked by Wall St. Rank hold ELOS as of Q3 2017.

  • Exane Asset Management reported no remaining Syneron Medical Ltd position as of Q3 2017 after selling out during the quarter.
  • Exane Asset Management sold 20,000 Syneron Medical Ltd shares in Q3 2017, an estimated $219K.
  • Exane Asset Management first reported a position in Syneron Medical Ltd in Q2 2017 and held it in 1 quarter.
  • Exane Asset Management's Syneron Medical Ltd position peaked at $219K in Q2 2017.
  • 4 funds tracked by Wall St. Rank held Syneron Medical Ltd as of Q3 2017.

Based on Exane Asset Management's 13F filing for Q3 2017, filed 13 Oct 2017.